Drug update: letrozole: A new aromatase inhibitor for metastatic breast cancer.
作者信息
Mays-Holland T
机构信息
Pharmacy Practice, College of Pharmacy, University of Utah, Salt Lake City.
出版信息
Cancer Pract. 1998 Nov-Dec;6(6):349-52. doi: 10.1046/j.1523-5394.1998.006006349.x.
Abstract
摘要
相似文献
1
Drug update: letrozole: A new aromatase inhibitor for metastatic breast cancer.药物进展：来曲唑：一种用于转移性乳腺癌的新型芳香化酶抑制剂。
Cancer Pract. 1998 Nov-Dec;6(6):349-52. doi: 10.1046/j.1523-5394.1998.006006349.x.
2
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.来曲唑（CGS 20267）。一种新型强效乳腺癌口服芳香化酶抑制剂的I期研究。
Cancer. 1995 Apr 15;75(8):2132-8. doi: 10.1002/1097-0142(19950415)75:8<2132::aid-cncr2820750816>3.0.co;2-u.
3
Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.在芳香酶抑制剂来曲唑的临床试验中止后，批评者对成功的代价提出质疑。
J Natl Cancer Inst. 2003 Dec 3;95(23):1738-9. doi: 10.1093/jnci/95.23.1738.
4
Beating breast cancer.战胜乳腺癌。
Nurs Stand. 2004;18(48):15. doi: 10.7748/ns.18.48.15.s28.
5
Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.
J Clin Oncol. 2003 Dec 15;21(24):4656; author reply 4657. doi: 10.1200/JCO.2003.99.152.
6
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifen.血清HER-2/neu与芳香化酶抑制剂来曲唑和他莫昔芬疗效的对比
J Clin Oncol. 2003 May 15;21(10):1967-72. doi: 10.1200/JCO.2003.09.098.
7
New aromatase inhibitors for breast cancer.用于乳腺癌的新型芳香化酶抑制剂。
Drug Ther Bull. 1997 Jul;35(7):55-6. doi: 10.1136/dtb.1997.35755.
8
Letrozole in breast cancer.来曲唑与乳腺癌
N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
9
Letrozole in breast cancer.来曲唑在乳腺癌中的应用
N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
10
The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Womens Health Issues. 2004 Jan-Feb;14(1):7-10. doi: 10.1016/j.whi.2003.12.006.
Zotero 插件